Overview Clinical Trial to Evaluate the Efficacy and Safety of JPI-289 in Patients With Acute Ischemic Stroke Status: Recruiting Trial end date: 2021-12-01 Target enrollment: Participant gender: Summary Clinical Trial to Evaluate the Efficacy and Safety of JPI-289 in Patients With Acute Ischemic Stroke Phase: Phase 2 Details Lead Sponsor: Jeil Pharmaceutical Co., Ltd.